Bausch + Lomb (BLCO) Stock Forecast & Price Target

$19.57 -0.24 (-1.21%)

(As of 11/22/2024 ET)

Bausch + Lomb - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 12 Analyst Ratings

Sell
0

Hold
5

Buy
7

Based on 12 Wall Street analysts who have issued ratings for Bausch + Lomb in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 12 analysts, 5 have given a hold rating, and 7 have given a buy rating for BLCO.

Consensus Price Target

$20.91
6.84% Upside

According to the 12 analysts' twelve-month price targets for Bausch + Lomb, the average price target is $20.91. The highest price target for BLCO is $26.00, while the lowest price target for BLCO is $17.00. The average price target represents a forecasted upside of 6.84% from the current price of $19.57.

Get the Latest News and Ratings for BLCO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Bausch + Lomb and its competitors.

BLCO Analyst Ratings Over Time

Type	Current Forecast 11/24/23 to 11/23/24	1 Month Ago 10/25/23 to 10/24/24	3 Months Ago 8/26/23 to 8/25/24	1 Year Ago 11/24/22 to 11/24/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	7 Buy rating(s)	7 Buy rating(s)	6 Buy rating(s)	4 Buy rating(s)
Hold	5 Hold rating(s)	5 Hold rating(s)	6 Hold rating(s)	4 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$20.91	$20.27	$18.59	$20.55
Forecasted Upside	6.84% Upside	0.46% Upside	14.26% Upside	33.01% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

BLCO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

BLCO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Bausch + Lomb Stock vs. The Competition

Type	Bausch + Lomb	Medical Companies	S&P 500
Consensus Rating Score	2.58	2.80	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	6.84% Upside	26,878.78% Upside	7.66% Upside
News Sentiment Rating	Neutral News See Recent BLCO News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/31/2024	Citigroup 3 of 5 stars		Boost Target	Buy ➝ Buy	$20.00 ➝ $24.00	+18.34%
10/31/2024	Wells Fargo & Company 3 of 5 stars		Boost Target	Overweight ➝ Overweight	$23.00 ➝ $26.00	+28.21%
10/31/2024	Needham & Company LLC 2 of 5 stars		Reiterated Rating	Hold
10/31/2024	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$22.00 ➝ $23.00	+12.52%
10/22/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$20.00 ➝ $23.00	+14.71%
10/15/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	V. Kumar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	In-Line ➝ Outperform	$19.00 ➝ $25.00	+19.90%
Get the Latest News and Ratings for BLCO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Bausch + Lomb and its competitors with MarketBeat's FREE daily newsletter.
9/23/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$16.00 ➝ $19.00	-4.81%
8/1/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$14.00 ➝ $18.00	+4.05%
8/1/2024	Evercore Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	In-Line	$15.50 ➝ $17.00	-1.85%
7/10/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	G. Nachman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$19.00	+23.94%
5/6/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Equal Weight ➝ Overweight	$16.00 ➝ $18.00	+32.35%
2/26/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$17.00 ➝ $18.00	+2.27%
8/3/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy	$22.00 ➝ $25.00	+34.48%
7/3/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$19.00 ➝ $23.00	+14.60%
2/23/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral	$15.00 ➝ $17.00	-6.64%
11/23/2022	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Amit Hazan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Neutral	$19.00 ➝ $17.00	+14.25%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 05:06 AM ET.

BLCO Forecast - Frequently Asked Questions

: According to the research reports of 12 Wall Street equities research analysts, the average twelve-month stock price forecast for Bausch + Lomb is $20.91, with a high forecast of $26.00 and a low forecast of $17.00.
: 12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bausch + Lomb in the last twelve months. There are currently 5 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" BLCO shares.
: According to analysts, Bausch + Lomb's stock has a predicted upside of 6.84% based on their 12-month stock forecasts.
: Over the previous 90 days, Bausch + Lomb's stock had 1 upgrade by analysts.
: Bausch + Lomb has been rated by research analysts at Citigroup, Evercore ISI, HC Wainwright, Needham & Company LLC, Royal Bank of Canada, Stifel Nicolaus, and Wells Fargo & Company in the past 90 days.
: Analysts like Bausch + Lomb less than other "medical" companies. The consensus rating score for Bausch + Lomb is 2.58 while the average consensus rating score for "medical" companies is 2.80. Learn more on how BLCO compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Trump won. Buy this coin now. (Ad)

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

This could be his favorite coin.

This page (NYSE:BLCO) was last updated on 11/23/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bausch + Lomb (BLCO) Stock Forecast & Price Target